Pressure Points and Affordability of Revolutionary Therapies: California Creeping Toward Solutions
California’s efforts to find ways to make multimillion-dollar stem cell and gene therapies affordable and accessible inched forward this week as the state stem cell agency said it was looking into problems posed by a lack of transparency and standards for performance.
The update came at a meeting of the $12 billion California Institute f…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.